|
1
|
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.
|
Gastroenterology
|
1996
|
3.54
|
|
2
|
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
|
J Clin Oncol
|
2001
|
2.71
|
|
3
|
Quality of life in colorectal cancer. Stoma vs. nonstoma patients.
|
Dis Colon Rectum
|
1995
|
2.15
|
|
4
|
Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis.
|
Gut
|
1997
|
1.88
|
|
5
|
Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA.
|
Am J Clin Pathol
|
1996
|
1.84
|
|
6
|
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
|
Cancer
|
1998
|
1.49
|
|
7
|
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC).
|
Int J Cancer
|
1996
|
1.35
|
|
8
|
Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.
|
Ann Oncol
|
2001
|
1.33
|
|
9
|
Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance.
|
Gastroenterology
|
1997
|
1.30
|
|
10
|
Expression of oestrogen receptor and loss of E-cadherin are diagnostic for gastric metastasis of breast carcinoma.
|
Histopathology
|
2005
|
1.27
|
|
11
|
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.
|
Gut
|
1994
|
1.09
|
|
12
|
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families.
|
Eur J Cancer
|
1995
|
1.04
|
|
13
|
Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.
|
Nucl Med Commun
|
2002
|
1.04
|
|
14
|
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
|
J Clin Oncol
|
1989
|
1.01
|
|
15
|
Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting.
|
Ann Oncol
|
1994
|
1.00
|
|
16
|
Probabilities for a probabilistic network: a case study in oesophageal cancer.
|
Artif Intell Med
|
2002
|
0.98
|
|
17
|
Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey.
|
Ann Oncol
|
1999
|
0.98
|
|
18
|
Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach.
|
Radiother Oncol
|
1988
|
0.96
|
|
19
|
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites.
|
Br J Cancer
|
2003
|
0.95
|
|
20
|
Non-allelic heterogeneity of familial adenomatous polyposis.
|
Am J Med Genet
|
1993
|
0.92
|
|
21
|
EAP in advanced gastric cancer.
|
J Clin Oncol
|
1990
|
0.91
|
|
22
|
A tumour with a neuroendocrine and papillary serous component: two or a pair?
|
J Clin Pathol
|
2002
|
0.91
|
|
23
|
Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria.
|
Hepatogastroenterology
|
1983
|
0.89
|
|
24
|
The role of I-131-MIBG in the diagnosis and therapy of carcinoids.
|
Eur J Nucl Med
|
1987
|
0.88
|
|
25
|
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication.
|
Gut
|
2006
|
0.88
|
|
26
|
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
|
Br J Cancer
|
2004
|
0.87
|
|
27
|
Computer-based decision support in the management of primary gastric non-Hodgkin lymphoma.
|
Methods Inf Med
|
1998
|
0.85
|
|
28
|
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.
|
Cancer Chemother Pharmacol
|
1992
|
0.83
|
|
29
|
Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody.
|
J Histochem Cytochem
|
2000
|
0.82
|
|
30
|
Serum IgM in primary biliary cirrhosis.
|
Clin Chim Acta
|
1980
|
0.82
|
|
31
|
Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.
|
Nucl Med Commun
|
1995
|
0.82
|
|
32
|
Pleuropulmonary fibrosis associated with chronic and excessive intake of ergotamine.
|
Thorax
|
1983
|
0.81
|
|
33
|
An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival.
|
Ann Oncol
|
2011
|
0.81
|
|
34
|
Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis.
|
Liver
|
1983
|
0.81
|
|
35
|
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
|
Eur J Cancer
|
1996
|
0.80
|
|
36
|
A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour.
|
Eur J Cancer
|
1992
|
0.80
|
|
37
|
Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
|
Eur J Gastroenterol Hepatol
|
1999
|
0.80
|
|
38
|
Carcinoid heart disease: an update.
|
Scand J Gastroenterol Suppl
|
2002
|
0.78
|
|
39
|
Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours.
|
Br J Cancer
|
2011
|
0.78
|
|
40
|
CagA+ H. pylori strains and gastric lymphoma.
|
Gastroenterology
|
1997
|
0.78
|
|
41
|
[Periodic colonoscopic examinations of persons with a positive family history for colorectal cancer. Work Group 'Hereditary non-polyposis- colon-rectum cancers'].
|
Ned Tijdschr Geneeskd
|
1999
|
0.78
|
|
42
|
Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis.
|
Eur J Surg Oncol
|
1993
|
0.77
|
|
43
|
Risk factors for the development of oesophageal cancer as a second primary tumour.
|
Eur J Cancer
|
1995
|
0.77
|
|
44
|
High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients.
|
J Pharm Biomed Anal
|
1994
|
0.77
|
|
45
|
Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours.
|
Endocr Relat Cancer
|
2004
|
0.77
|
|
46
|
Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids.
|
J Endocrinol Invest
|
2010
|
0.77
|
|
47
|
Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG.
|
Nucl Med Commun
|
2000
|
0.76
|
|
48
|
Intraperitoneal chemotherapy for malignant peritoneal mesothelioma.
|
Eur J Cancer
|
1991
|
0.76
|
|
49
|
Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.
|
Clin Nucl Med
|
1986
|
0.75
|
|
50
|
Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
|
J Nucl Biol Med
|
1992
|
0.75
|
|
51
|
Hepatic failure due to liver metastases in breast cancer.
|
Neth J Med
|
1985
|
0.75
|
|
52
|
Carcinoid tumors.
|
N Engl J Med
|
1999
|
0.75
|
|
53
|
Comment on radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma.
|
Radiother Oncol
|
1998
|
0.75
|
|
54
|
Bioavailability of oral etoposide in gastric cancer.
|
Eur J Cancer
|
1994
|
0.75
|
|
55
|
Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group.
|
Br J Cancer
|
1995
|
0.75
|
|
56
|
Gastrointestinal metastases in lobular breast cancer.
|
Ann Oncol
|
2001
|
0.75
|
|
57
|
[Current possibilities in the treatment of severe stenosis of the major airways].
|
Ned Tijdschr Geneeskd
|
1992
|
0.75
|
|
58
|
[Helicobacter pylori infection and lymphoma of the stomach].
|
Ned Tijdschr Geneeskd
|
1995
|
0.75
|
|
59
|
Comment on "Adjuvant treatment of colon cancer. A plea for a large-scale European trial".
|
Neth J Med
|
1994
|
0.75
|
|
60
|
Sequential 75SeHCAT imaging in addition to the conventional 75SeHCAT test: a necessity.
|
Eur J Nucl Med
|
1995
|
0.75
|
|
61
|
Experience of discharge from colonoscopy of mutation negative HNPCC family members.
|
J Med Genet
|
2003
|
0.75
|
|
62
|
[Diagnosis and therapy of neural crest tumors using I131 iodobenzylguanidine].
|
Ned Tijdschr Geneeskd
|
1988
|
0.75
|
|
63
|
Studies in primary biliary cirrhosis.
|
Neth J Med
|
1981
|
0.75
|
|
64
|
Primary biliary cirrhosis: a changing clinical presentation.
|
Neth J Med
|
1981
|
0.75
|
|
65
|
[Second tumors following treatment of Hodgkin's disease].
|
Ned Tijdschr Geneeskd
|
1988
|
0.75
|
|
66
|
Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study.
|
Pharmacol Res
|
2000
|
0.75
|
|
67
|
Monomeric (7S) IgM in primary biliary cirrhosis.
|
Scand J Gastroenterol
|
1982
|
0.75
|
|
68
|
5-Fluorouracil plus tauromustine in advanced colorectal cancer: unexpected negative results.
|
Eur J Cancer
|
1990
|
0.75
|
|
69
|
Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy.
|
Z Gastroenterol
|
1985
|
0.75
|
|
70
|
Long-term survival in two cases of colorectal carcinoma following a new chemotherapy regimen and subsequent metastasectomy.
|
Eur J Surg Oncol
|
1995
|
0.75
|
|
71
|
Evaluation of a probabilistic model for staging of oesophageal carcinoma.
|
Stud Health Technol Inform
|
2000
|
0.75
|
|
72
|
[The treatment of pancreatic carcinoma with cytostatic agents].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
73
|
[Treatment of colonic carcinoma with cytostatic agents].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
74
|
[Cytostatic agents in the treatment of stomach carcinoma].
|
Ned Tijdschr Geneeskd
|
1987
|
0.75
|
|
75
|
Gastrointestinal lymphomas--the Dutch experience.
|
Recent Results Cancer Res
|
2000
|
0.75
|
|
76
|
Bioanalysis of m-iodobenzylguanidine in plasma by high-performance liquid chromatography after derivatization with benzoin.
|
J Chromatogr B Biomed Sci Appl
|
1999
|
0.75
|
|
77
|
[Sealing esophagobronchial fistulae: better results with self expanding stents than with an esophagobronchial fistula].
|
Ned Tijdschr Geneeskd
|
1998
|
0.75
|
|
78
|
Tauromustine (TCNU) combined with 5-fluorouracil and leucovorin in the treatment of advanced colon cancer.
|
Eur J Cancer
|
1993
|
0.75
|
|
79
|
Surgical repair of radiation damage of the rectum: a systematic approach to a difficult problem.
|
Eur J Surg Oncol
|
1988
|
0.75
|
|
80
|
[Acute liver insufficiency caused by rifampicin-isoniazid].
|
Ned Tijdschr Geneeskd
|
1980
|
0.75
|
|
81
|
Treatment of liver metastases from colorectal cancer with continuous high dose intra-arterial floxuridine (FUDR) and systemic fluorouracil: a phase II study.
|
Eur J Cancer Clin Oncol
|
1989
|
0.75
|
|
82
|
Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.
|
Neth J Med
|
1988
|
0.75
|